Main diagnosis (ICD9CM);Type of variable;Sex;Total ALL CAUSES (see exceptions in the methodology);patients discharged per 100,000 inhabitants;both sexes;10,246 ALL CAUSES (see exceptions in the methodology);patients discharged per 100,000 inhabitants;males;9,655 ALL CAUSES (see exceptions in the methodology);patients discharged per 100,000 inhabitants;females;10,820 ALL CAUSES (see exceptions in the methodology);Average Stay by patient;both sexes;7 ALL CAUSES (see exceptions in the methodology);Average Stay by patient;males;7 ALL CAUSES (see exceptions in the methodology);Average Stay by patient;females;6 INFECTIOUS AND PARASITIC DISEASES 001-139 I;patients discharged per 100,000 inhabitants;both sexes;176 INFECTIOUS AND PARASITIC DISEASES 001-139 I;patients discharged per 100,000 inhabitants;males;204 INFECTIOUS AND PARASITIC DISEASES 001-139 I;patients discharged per 100,000 inhabitants;females;149 INFECTIOUS AND PARASITIC DISEASES 001-139 I;Average Stay by patient;both sexes;9 INFECTIOUS AND PARASITIC DISEASES 001-139 I;Average Stay by patient;males;9 INFECTIOUS AND PARASITIC DISEASES 001-139 I;Average Stay by patient;females;9 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;patients discharged per 100,000 inhabitants;both sexes;43 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;patients discharged per 100,000 inhabitants;males;45 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;patients discharged per 100,000 inhabitants;females;40 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;Average Stay by patient;both sexes;5 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;Average Stay by patient;males;5 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;Average Stay by patient;females;5 Food poisoning 003,005;patients discharged per 100,000 inhabitants;both sexes;8 Food poisoning 003,005;patients discharged per 100,000 inhabitants;males;9 Food poisoning 003,005;patients discharged per 100,000 inhabitants;females;7 Food poisoning 003,005;Average Stay by patient;both sexes;5 Food poisoning 003,005;Average Stay by patient;males;6 Food poisoning 003,005;Average Stay by patient;females;5 Imprecise intestinal infections 009;patients discharged per 100,000 inhabitants;both sexes;15 Imprecise intestinal infections 009;patients discharged per 100,000 inhabitants;males;14 Imprecise intestinal infections 009;patients discharged per 100,000 inhabitants;females;15 Imprecise intestinal infections 009;Average Stay by patient;both sexes;4 Imprecise intestinal infections 009;Average Stay by patient;males;4 Imprecise intestinal infections 009;Average Stay by patient;females;4 Other intestinal infectious diseases Rest (001-009);patients discharged per 100,000 inhabitants;both sexes;20 Other intestinal infectious diseases Rest (001-009);patients discharged per 100,000 inhabitants;males;22 Other intestinal infectious diseases Rest (001-009);patients discharged per 100,000 inhabitants;females;19 Other intestinal infectious diseases Rest (001-009);Average Stay by patient;both sexes;5 Other intestinal infectious diseases Rest (001-009);Average Stay by patient;males;5 Other intestinal infectious diseases Rest (001-009);Average Stay by patient;females;5 TUBERCULOSIS 010-018 I.2;patients discharged per 100,000 inhabitants;both sexes;12 TUBERCULOSIS 010-018 I.2;patients discharged per 100,000 inhabitants;males;16 TUBERCULOSIS 010-018 I.2;patients discharged per 100,000 inhabitants;females;8 TUBERCULOSIS 010-018 I.2;Average Stay by patient;both sexes;15 TUBERCULOSIS 010-018 I.2;Average Stay by patient;males;16 TUBERCULOSIS 010-018 I.2;Average Stay by patient;females;13 Tuberculosis of the respiratory system 010-012;patients discharged per 100,000 inhabitants;both sexes;9 Tuberculosis of the respiratory system 010-012;patients discharged per 100,000 inhabitants;males;12 Tuberculosis of the respiratory system 010-012;patients discharged per 100,000 inhabitants;females;6 Tuberculosis of the respiratory system 010-012;Average Stay by patient;both sexes;14 Tuberculosis of the respiratory system 010-012;Average Stay by patient;males;14 Tuberculosis of the respiratory system 010-012;Average Stay by patient;females;12 Other tuberculosis Rest (010-018);patients discharged per 100,000 inhabitants;both sexes;3 Other tuberculosis Rest (010-018);patients discharged per 100,000 inhabitants;males;3 Other tuberculosis Rest (010-018);patients discharged per 100,000 inhabitants;females;2 Other tuberculosis Rest (010-018);Average Stay by patient;both sexes;20 Other tuberculosis Rest (010-018);Average Stay by patient;males;21 Other tuberculosis Rest (010-018);Average Stay by patient;females;18 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;patients discharged per 100,000 inhabitants;both sexes;54 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;patients discharged per 100,000 inhabitants;males;59 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;patients discharged per 100,000 inhabitants;females;50 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;Average Stay by patient;both sexes;12 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;Average Stay by patient;males;12 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;Average Stay by patient;females;12 Meningococcal Infection 036;patients discharged per 100,000 inhabitants;both sexes;1 Meningococcal Infection 036;patients discharged per 100,000 inhabitants;males;1 Meningococcal Infection 036;patients discharged per 100,000 inhabitants;females;1 Meningococcal Infection 036;Average Stay by patient;both sexes;11 Meningococcal Infection 036;Average Stay by patient;males;10 Meningococcal Infection 036;Average Stay by patient;females;11 Septicemia 038;patients discharged per 100,000 inhabitants;both sexes;46 Septicemia 038;patients discharged per 100,000 inhabitants;males;50 Septicemia 038;patients discharged per 100,000 inhabitants;females;42 Septicemia 038;Average Stay by patient;both sexes;12 Septicemia 038;Average Stay by patient;males;13 Septicemia 038;Average Stay by patient;females;12 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);patients discharged per 100,000 inhabitants;both sexes;7 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);patients discharged per 100,000 inhabitants;males;8 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);patients discharged per 100,000 inhabitants;females;7 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);Average Stay by patient;both sexes;10 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);Average Stay by patient;males;11 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);Average Stay by patient;females;9 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;patients discharged per 100,000 inhabitants;both sexes;55 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;patients discharged per 100,000 inhabitants;males;69 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;patients discharged per 100,000 inhabitants;females;41 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;Average Stay by patient;both sexes;7 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;Average Stay by patient;males;8 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;Average Stay by patient;females;7 Illness caused by the human immunodeficiency virus (HIV) 042 *;patients discharged per 100,000 inhabitants;both sexes;11 Illness caused by the human immunodeficiency virus (HIV) 042 *;patients discharged per 100,000 inhabitants;males;17 Illness caused by the human immunodeficiency virus (HIV) 042 *;patients discharged per 100,000 inhabitants;females;5 Illness caused by the human immunodeficiency virus (HIV) 042 *;Average Stay by patient;both sexes;14 Illness caused by the human immunodeficiency virus (HIV) 042 *;Average Stay by patient;males;14 Illness caused by the human immunodeficiency virus (HIV) 042 *;Average Stay by patient;females;13 Viral hepatitis 070;patients discharged per 100,000 inhabitants;both sexes;10 Viral hepatitis 070;patients discharged per 100,000 inhabitants;males;14 Viral hepatitis 070;patients discharged per 100,000 inhabitants;females;7 Viral hepatitis 070;Average Stay by patient;both sexes;6 Viral hepatitis 070;Average Stay by patient;males;5 Viral hepatitis 070;Average Stay by patient;females;7 Other viral diseases Rest (042-079);patients discharged per 100,000 inhabitants;both sexes;34 Other viral diseases Rest (042-079);patients discharged per 100,000 inhabitants;males;38 Other viral diseases Rest (042-079);patients discharged per 100,000 inhabitants;females;29 Other viral diseases Rest (042-079);Average Stay by patient;both sexes;6 Other viral diseases Rest (042-079);Average Stay by patient;males;6 Other viral diseases Rest (042-079);Average Stay by patient;females;6 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;patients discharged per 100,000 inhabitants;both sexes;12 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;patients discharged per 100,000 inhabitants;males;15 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;patients discharged per 100,000 inhabitants;females;10 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;Average Stay by patient;both sexes;12 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;Average Stay by patient;males;12 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;Average Stay by patient;females;12 TUMOURS 140-239 II;patients discharged per 100,000 inhabitants;both sexes;950 TUMOURS 140-239 II;patients discharged per 100,000 inhabitants;males;1,009 TUMOURS 140-239 II;patients discharged per 100,000 inhabitants;females;893 TUMOURS 140-239 II;Average Stay by patient;both sexes;9 TUMOURS 140-239 II;Average Stay by patient;males;9 TUMOURS 140-239 II;Average Stay by patient;females;8 MALIGNANT TUMOURS 140-209 II.1;patients discharged per 100,000 inhabitants;both sexes;737 MALIGNANT TUMOURS 140-209 II.1;patients discharged per 100,000 inhabitants;males;868 MALIGNANT TUMOURS 140-209 II.1;patients discharged per 100,000 inhabitants;females;609 MALIGNANT TUMOURS 140-209 II.1;Average Stay by patient;both sexes;10 MALIGNANT TUMOURS 140-209 II.1;Average Stay by patient;males;10 MALIGNANT TUMOURS 140-209 II.1;Average Stay by patient;females;9 Malignant neoplasm of the oesophagus 150;patients discharged per 100,000 inhabitants;both sexes;8 Malignant neoplasm of the oesophagus 150;patients discharged per 100,000 inhabitants;males;14 Malignant neoplasm of the oesophagus 150;patients discharged per 100,000 inhabitants;females;2 Malignant neoplasm of the oesophagus 150;Average Stay by patient;both sexes;14 Malignant neoplasm of the oesophagus 150;Average Stay by patient;males;13 Malignant neoplasm of the oesophagus 150;Average Stay by patient;females;14 Malignant neoplasm of the stomach 151;patients discharged per 100,000 inhabitants;both sexes;25 Malignant neoplasm of the stomach 151;patients discharged per 100,000 inhabitants;males;32 Malignant neoplasm of the stomach 151;patients discharged per 100,000 inhabitants;females;18 Malignant neoplasm of the stomach 151;Average Stay by patient;both sexes;15 Malignant neoplasm of the stomach 151;Average Stay by patient;males;15 Malignant neoplasm of the stomach 151;Average Stay by patient;females;15 Malignant neoplasm of the colon and rectum 153-154;patients discharged per 100,000 inhabitants;both sexes;94 Malignant neoplasm of the colon and rectum 153-154;patients discharged per 100,000 inhabitants;males;114 Malignant neoplasm of the colon and rectum 153-154;patients discharged per 100,000 inhabitants;females;74 Malignant neoplasm of the colon and rectum 153-154;Average Stay by patient;both sexes;14 Malignant neoplasm of the colon and rectum 153-154;Average Stay by patient;males;14 Malignant neoplasm of the colon and rectum 153-154;Average Stay by patient;females;13 Malignant tumour of the larynx 161;patients discharged per 100,000 inhabitants;both sexes;12 Malignant tumour of the larynx 161;patients discharged per 100,000 inhabitants;males;24 Malignant tumour of the larynx 161;patients discharged per 100,000 inhabitants;females;1 Malignant tumour of the larynx 161;Average Stay by patient;both sexes;12 Malignant tumour of the larynx 161;Average Stay by patient;males;12 Malignant tumour of the larynx 161;Average Stay by patient;females;11 Malignant neoplasm of trachea, bronchus and lung 162;patients discharged per 100,000 inhabitants;both sexes;70 Malignant neoplasm of trachea, bronchus and lung 162;patients discharged per 100,000 inhabitants;males;118 Malignant neoplasm of trachea, bronchus and lung 162;patients discharged per 100,000 inhabitants;females;23 Malignant neoplasm of trachea, bronchus and lung 162;Average Stay by patient;both sexes;10 Malignant neoplasm of trachea, bronchus and lung 162;Average Stay by patient;males;10 Malignant neoplasm of trachea, bronchus and lung 162;Average Stay by patient;females;11 Malignant tumour of the skin 172-173 *;patients discharged per 100,000 inhabitants;both sexes;21 Malignant tumour of the skin 172-173 *;patients discharged per 100,000 inhabitants;males;24 Malignant tumour of the skin 172-173 *;patients discharged per 100,000 inhabitants;females;17 Malignant tumour of the skin 172-173 *;Average Stay by patient;both sexes;4 Malignant tumour of the skin 172-173 *;Average Stay by patient;males;4 Malignant tumour of the skin 172-173 *;Average Stay by patient;females;5 Malignant neoplasm of the breast 174-175;patients discharged per 100,000 inhabitants;both sexes;70 Malignant neoplasm of the breast 174-175;patients discharged per 100,000 inhabitants;males;1 Malignant neoplasm of the breast 174-175;patients discharged per 100,000 inhabitants;females;137 Malignant neoplasm of the breast 174-175;Average Stay by patient;both sexes;5 Malignant neoplasm of the breast 174-175;Average Stay by patient;males;5 Malignant neoplasm of the breast 174-175;Average Stay by patient;females;5 Malignant tumour of the uterus 179-180.182 *;patients discharged per 100,000 inhabitants;both sexes;22 Malignant tumour of the uterus 179-180.182 *;patients discharged per 100,000 inhabitants;males;.. Malignant tumour of the uterus 179-180.182 *;patients discharged per 100,000 inhabitants;females;43 Malignant tumour of the uterus 179-180.182 *;Average Stay by patient;both sexes;7 Malignant tumour of the uterus 179-180.182 *;Average Stay by patient;males;.. Malignant tumour of the uterus 179-180.182 *;Average Stay by patient;females;7 Malignant tumour of the prostate 185;patients discharged per 100,000 inhabitants;both sexes;37 Malignant tumour of the prostate 185;patients discharged per 100,000 inhabitants;males;76 Malignant tumour of the prostate 185;patients discharged per 100,000 inhabitants;females;.. Malignant tumour of the prostate 185;Average Stay by patient;both sexes;6 Malignant tumour of the prostate 185;Average Stay by patient;males;6 Malignant tumour of the prostate 185;Average Stay by patient;females;.. Malignant tumour of the bladder 188 *;patients discharged per 100,000 inhabitants;both sexes;83 Malignant tumour of the bladder 188 *;patients discharged per 100,000 inhabitants;males;142 Malignant tumour of the bladder 188 *;patients discharged per 100,000 inhabitants;females;25 Malignant tumour of the bladder 188 *;Average Stay by patient;both sexes;5 Malignant tumour of the bladder 188 *;Average Stay by patient;males;5 Malignant tumour of the bladder 188 *;Average Stay by patient;females;5 Lymphomas 200-202;patients discharged per 100,000 inhabitants;both sexes;27 Lymphomas 200-202;patients discharged per 100,000 inhabitants;males;31 Lymphomas 200-202;patients discharged per 100,000 inhabitants;females;23 Lymphomas 200-202;Average Stay by patient;both sexes;13 Lymphomas 200-202;Average Stay by patient;males;13 Lymphomas 200-202;Average Stay by patient;females;13 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;patients discharged per 100,000 inhabitants;both sexes;28 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;patients discharged per 100,000 inhabitants;males;32 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;patients discharged per 100,000 inhabitants;females;24 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;Average Stay by patient;both sexes;17 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;Average Stay by patient;males;17 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;Average Stay by patient;females;17 Other malignant neoplasms Rest (140-209);patients discharged per 100,000 inhabitants;both sexes;240 Other malignant neoplasms Rest (140-209);patients discharged per 100,000 inhabitants;males;262 Other malignant neoplasms Rest (140-209);patients discharged per 100,000 inhabitants;females;219 Other malignant neoplasms Rest (140-209);Average Stay by patient;both sexes;10 Other malignant neoplasms Rest (140-209);Average Stay by patient;males;10 Other malignant neoplasms Rest (140-209);Average Stay by patient;females;10 BENIGN TUMOURS 210-229 II.2;patients discharged per 100,000 inhabitants;both sexes;148 BENIGN TUMOURS 210-229 II.2;patients discharged per 100,000 inhabitants;males;75 BENIGN TUMOURS 210-229 II.2;patients discharged per 100,000 inhabitants;females;218 BENIGN TUMOURS 210-229 II.2;Average Stay by patient;both sexes;5 BENIGN TUMOURS 210-229 II.2;Average Stay by patient;males;5 BENIGN TUMOURS 210-229 II.2;Average Stay by patient;females;4 Uterine leiomyoma 218 *;patients discharged per 100,000 inhabitants;both sexes;52 Uterine leiomyoma 218 *;patients discharged per 100,000 inhabitants;males;.. Uterine leiomyoma 218 *;patients discharged per 100,000 inhabitants;females;102 Uterine leiomyoma 218 *;Average Stay by patient;both sexes;4 Uterine leiomyoma 218 *;Average Stay by patient;males;.. Uterine leiomyoma 218 *;Average Stay by patient;females;4 Other benign tumours of the uterus 219 *;patients discharged per 100,000 inhabitants;both sexes;1 Other benign tumours of the uterus 219 *;patients discharged per 100,000 inhabitants;males;.. Other benign tumours of the uterus 219 *;patients discharged per 100,000 inhabitants;females;2 Other benign tumours of the uterus 219 *;Average Stay by patient;both sexes;4 Other benign tumours of the uterus 219 *;Average Stay by patient;males;.. Other benign tumours of the uterus 219 *;Average Stay by patient;females;4 Other benign tumours Rest (210-229);patients discharged per 100,000 inhabitants;both sexes;95 Other benign tumours Rest (210-229);patients discharged per 100,000 inhabitants;males;75 Other benign tumours Rest (210-229);patients discharged per 100,000 inhabitants;females;114 Other benign tumours Rest (210-229);Average Stay by patient;both sexes;5 Other benign tumours Rest (210-229);Average Stay by patient;males;5 Other benign tumours Rest (210-229);Average Stay by patient;females;5 PREINVASIVE CARCINOMA 230-234 II.3;patients discharged per 100,000 inhabitants;both sexes;17 PREINVASIVE CARCINOMA 230-234 II.3;patients discharged per 100,000 inhabitants;males;11 PREINVASIVE CARCINOMA 230-234 II.3;patients discharged per 100,000 inhabitants;females;24 PREINVASIVE CARCINOMA 230-234 II.3;Average Stay by patient;both sexes;5 PREINVASIVE CARCINOMA 230-234 II.3;Average Stay by patient;males;7 PREINVASIVE CARCINOMA 230-234 II.3;Average Stay by patient;females;4 NON SPECIFIED TUMOURS 235-239 II.4;patients discharged per 100,000 inhabitants;both sexes;48 NON SPECIFIED TUMOURS 235-239 II.4;patients discharged per 100,000 inhabitants;males;54 NON SPECIFIED TUMOURS 235-239 II.4;patients discharged per 100,000 inhabitants;females;43 NON SPECIFIED TUMOURS 235-239 II.4;Average Stay by patient;both sexes;6 NON SPECIFIED TUMOURS 235-239 II.4;Average Stay by patient;males;6 NON SPECIFIED TUMOURS 235-239 II.4;Average Stay by patient;females;6 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;patients discharged per 100,000 inhabitants;both sexes;187 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;patients discharged per 100,000 inhabitants;males;154 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;patients discharged per 100,000 inhabitants;females;219 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;Average Stay by patient;both sexes;7 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;Average Stay by patient;males;8 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;Average Stay by patient;females;6 DISORDERS OF THE THYROID GLAND 240-246 III.1;patients discharged per 100,000 inhabitants;both sexes;39 DISORDERS OF THE THYROID GLAND 240-246 III.1;patients discharged per 100,000 inhabitants;males;14 DISORDERS OF THE THYROID GLAND 240-246 III.1;patients discharged per 100,000 inhabitants;females;63 DISORDERS OF THE THYROID GLAND 240-246 III.1;Average Stay by patient;both sexes;3 DISORDERS OF THE THYROID GLAND 240-246 III.1;Average Stay by patient;males;4 DISORDERS OF THE THYROID GLAND 240-246 III.1;Average Stay by patient;females;3 Diseases of other endocrine glands 249-259 III.2;patients discharged per 100,000 inhabitants;both sexes;81 Diseases of other endocrine glands 249-259 III.2;patients discharged per 100,000 inhabitants;males;86 Diseases of other endocrine glands 249-259 III.2;patients discharged per 100,000 inhabitants;females;75 Diseases of other endocrine glands 249-259 III.2;Average Stay by patient;both sexes;8 Diseases of other endocrine glands 249-259 III.2;Average Stay by patient;males;9 Diseases of other endocrine glands 249-259 III.2;Average Stay by patient;females;8 Diabetes mellitus 249-250;patients discharged per 100,000 inhabitants;both sexes;68 Diabetes mellitus 249-250;patients discharged per 100,000 inhabitants;males;77 Diabetes mellitus 249-250;patients discharged per 100,000 inhabitants;females;59 Diabetes mellitus 249-250;Average Stay by patient;both sexes;9 Diabetes mellitus 249-250;Average Stay by patient;males;9 Diabetes mellitus 249-250;Average Stay by patient;females;8 Other diseases of the endocrine glands Rest (249-259);patients discharged per 100,000 inhabitants;both sexes;13 Other diseases of the endocrine glands Rest (249-259);patients discharged per 100,000 inhabitants;males;9 Other diseases of the endocrine glands Rest (249-259);patients discharged per 100,000 inhabitants;females;16 Other diseases of the endocrine glands Rest (249-259);Average Stay by patient;both sexes;6 Other diseases of the endocrine glands Rest (249-259);Average Stay by patient;males;7 Other diseases of the endocrine glands Rest (249-259);Average Stay by patient;females;6 NUTRITIONAL DEFICIENCIES 260-269 III.3;patients discharged per 100,000 inhabitants;both sexes;3 NUTRITIONAL DEFICIENCIES 260-269 III.3;patients discharged per 100,000 inhabitants;males;3 NUTRITIONAL DEFICIENCIES 260-269 III.3;patients discharged per 100,000 inhabitants;females;3 NUTRITIONAL DEFICIENCIES 260-269 III.3;Average Stay by patient;both sexes;14 NUTRITIONAL DEFICIENCIES 260-269 III.3;Average Stay by patient;males;14 NUTRITIONAL DEFICIENCIES 260-269 III.3;Average Stay by patient;females;14 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;patients discharged per 100,000 inhabitants;both sexes;64 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;patients discharged per 100,000 inhabitants;males;51 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;patients discharged per 100,000 inhabitants;females;77 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;Average Stay by patient;both sexes;7 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;Average Stay by patient;males;7 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;Average Stay by patient;females;7 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;patients discharged per 100,000 inhabitants;both sexes;95 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;patients discharged per 100,000 inhabitants;males;92 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;patients discharged per 100,000 inhabitants;females;97 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;Average Stay by patient;both sexes;7 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;Average Stay by patient;males;7 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;Average Stay by patient;females;7 Anaemia 280-285;patients discharged per 100,000 inhabitants;both sexes;56 Anaemia 280-285;patients discharged per 100,000 inhabitants;males;52 Anaemia 280-285;patients discharged per 100,000 inhabitants;females;59 Anaemia 280-285;Average Stay by patient;both sexes;8 Anaemia 280-285;Average Stay by patient;males;8 Anaemia 280-285;Average Stay by patient;females;7 Other diseases of the blood and blood forming organs Rest (280-289);patients discharged per 100,000 inhabitants;both sexes;39 Other diseases of the blood and blood forming organs Rest (280-289);patients discharged per 100,000 inhabitants;males;40 Other diseases of the blood and blood forming organs Rest (280-289);patients discharged per 100,000 inhabitants;females;37 Other diseases of the blood and blood forming organs Rest (280-289);Average Stay by patient;both sexes;7 Other diseases of the blood and blood forming organs Rest (280-289);Average Stay by patient;males;7 Other diseases of the blood and blood forming organs Rest (280-289);Average Stay by patient;females;6 MENTAL DISORDERS 290-319 V;patients discharged per 100,000 inhabitants;both sexes;249 MENTAL DISORDERS 290-319 V;patients discharged per 100,000 inhabitants;males;270 MENTAL DISORDERS 290-319 V;patients discharged per 100,000 inhabitants;females;228 MENTAL DISORDERS 290-319 V;Average Stay by patient;both sexes;26 MENTAL DISORDERS 290-319 V;Average Stay by patient;males;27 MENTAL DISORDERS 290-319 V;Average Stay by patient;females;26 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;patients discharged per 100,000 inhabitants;both sexes;175 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;patients discharged per 100,000 inhabitants;males;207 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;patients discharged per 100,000 inhabitants;females;144 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;Average Stay by patient;both sexes;26 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;Average Stay by patient;males;25 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;Average Stay by patient;females;27 Senile and presenile organic psychotic conditions (see methodology) 290;patients discharged per 100,000 inhabitants;both sexes;9 Senile and presenile organic psychotic conditions (see methodology) 290;patients discharged per 100,000 inhabitants;males;8 Senile and presenile organic psychotic conditions (see methodology) 290;patients discharged per 100,000 inhabitants;females;10 Senile and presenile organic psychotic conditions (see methodology) 290;Average Stay by patient;both sexes;68 Senile and presenile organic psychotic conditions (see methodology) 290;Average Stay by patient;males;60 Senile and presenile organic psychotic conditions (see methodology) 290;Average Stay by patient;females;73 Schizophrenic disorders (see methodology) 295;patients discharged per 100,000 inhabitants;both sexes;51 Schizophrenic disorders (see methodology) 295;patients discharged per 100,000 inhabitants;males;67 Schizophrenic disorders (see methodology) 295;patients discharged per 100,000 inhabitants;females;35 Schizophrenic disorders (see methodology) 295;Average Stay by patient;both sexes;40 Schizophrenic disorders (see methodology) 295;Average Stay by patient;males;40 Schizophrenic disorders (see methodology) 295;Average Stay by patient;females;40 Mental and behavioural disorders induced by the use of alcohol 291.303;patients discharged per 100,000 inhabitants;both sexes;20 Mental and behavioural disorders induced by the use of alcohol 291.303;patients discharged per 100,000 inhabitants;males;31 Mental and behavioural disorders induced by the use of alcohol 291.303;patients discharged per 100,000 inhabitants;females;9 Mental and behavioural disorders induced by the use of alcohol 291.303;Average Stay by patient;both sexes;13 Mental and behavioural disorders induced by the use of alcohol 291.303;Average Stay by patient;males;12 Mental and behavioural disorders induced by the use of alcohol 291.303;Average Stay by patient;females;13 Mental and behavioural disorders induced by the use of drugs 292304-305 *;patients discharged per 100,000 inhabitants;both sexes;19 Mental and behavioural disorders induced by the use of drugs 292304-305 *;patients discharged per 100,000 inhabitants;males;29 Mental and behavioural disorders induced by the use of drugs 292304-305 *;patients discharged per 100,000 inhabitants;females;9 Mental and behavioural disorders induced by the use of drugs 292304-305 *;Average Stay by patient;both sexes;11 Mental and behavioural disorders induced by the use of drugs 292304-305 *;Average Stay by patient;males;11 Mental and behavioural disorders induced by the use of drugs 292304-305 *;Average Stay by patient;females;11 Other psychosis 293-294.296-299 *;patients discharged per 100,000 inhabitants;both sexes;77 Other psychosis 293-294.296-299 *;patients discharged per 100,000 inhabitants;males;71 Other psychosis 293-294.296-299 *;patients discharged per 100,000 inhabitants;females;81 Other psychosis 293-294.296-299 *;Average Stay by patient;both sexes;20 Other psychosis 293-294.296-299 *;Average Stay by patient;males;19 Other psychosis 293-294.296-299 *;Average Stay by patient;females;20 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;patients discharged per 100,000 inhabitants;both sexes;74 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;patients discharged per 100,000 inhabitants;males;63 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;patients discharged per 100,000 inhabitants;females;84 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;Average Stay by patient;both sexes;27 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;Average Stay by patient;males;32 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;Average Stay by patient;females;23 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;patients discharged per 100,000 inhabitants;both sexes;71 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;patients discharged per 100,000 inhabitants;males;59 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;patients discharged per 100,000 inhabitants;females;81 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;Average Stay by patient;both sexes;13 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;Average Stay by patient;males;12 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;Average Stay by patient;females;14 Other mental disorders (see methodology ) Rest (300-302,306-319) *;patients discharged per 100,000 inhabitants;both sexes;3 Other mental disorders (see methodology ) Rest (300-302,306-319) *;patients discharged per 100,000 inhabitants;males;4 Other mental disorders (see methodology ) Rest (300-302,306-319) *;patients discharged per 100,000 inhabitants;females;2 Other mental disorders (see methodology ) Rest (300-302,306-319) *;Average Stay by patient;both sexes;332 Other mental disorders (see methodology ) Rest (300-302,306-319) *;Average Stay by patient;males;319 Other mental disorders (see methodology ) Rest (300-302,306-319) *;Average Stay by patient;females;356 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;patients discharged per 100,000 inhabitants;both sexes;316 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;patients discharged per 100,000 inhabitants;males;321 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;patients discharged per 100,000 inhabitants;females;311 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;Average Stay by patient;both sexes;6 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;Average Stay by patient;males;6 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;Average Stay by patient;females;6 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;patients discharged per 100,000 inhabitants;both sexes;177 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;patients discharged per 100,000 inhabitants;males;181 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;patients discharged per 100,000 inhabitants;females;174 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;Average Stay by patient;both sexes;9 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;Average Stay by patient;males;9 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;Average Stay by patient;females;9 Parkinson Disease 332;patients discharged per 100,000 inhabitants;both sexes;6 Parkinson Disease 332;patients discharged per 100,000 inhabitants;males;6 Parkinson Disease 332;patients discharged per 100,000 inhabitants;females;5 Parkinson Disease 332;Average Stay by patient;both sexes;15 Parkinson Disease 332;Average Stay by patient;males;14 Parkinson Disease 332;Average Stay by patient;females;15 Multiple sclerosis 340;patients discharged per 100,000 inhabitants;both sexes;6 Multiple sclerosis 340;patients discharged per 100,000 inhabitants;males;4 Multiple sclerosis 340;patients discharged per 100,000 inhabitants;females;8 Multiple sclerosis 340;Average Stay by patient;both sexes;7 Multiple sclerosis 340;Average Stay by patient;males;8 Multiple sclerosis 340;Average Stay by patient;females;6 Epilepsy 345;patients discharged per 100,000 inhabitants;both sexes;36 Epilepsy 345;patients discharged per 100,000 inhabitants;males;39 Epilepsy 345;patients discharged per 100,000 inhabitants;females;32 Epilepsy 345;Average Stay by patient;both sexes;6 Epilepsy 345;Average Stay by patient;males;6 Epilepsy 345;Average Stay by patient;females;6 Other diseases of the central nervous system Rest (320-359);patients discharged per 100,000 inhabitants;both sexes;130 Other diseases of the central nervous system Rest (320-359);patients discharged per 100,000 inhabitants;males;131 Other diseases of the central nervous system Rest (320-359);patients discharged per 100,000 inhabitants;females;129 Other diseases of the central nervous system Rest (320-359);Average Stay by patient;both sexes;10 Other diseases of the central nervous system Rest (320-359);Average Stay by patient;males;9 Other diseases of the central nervous system Rest (320-359);Average Stay by patient;females;10 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;patients discharged per 100,000 inhabitants;both sexes;84 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;patients discharged per 100,000 inhabitants;males;85 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;patients discharged per 100,000 inhabitants;females;82 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;Average Stay by patient;both sexes;3 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;Average Stay by patient;males;3 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;Average Stay by patient;females;3 Cataract 366 *;patients discharged per 100,000 inhabitants;both sexes;22 Cataract 366 *;patients discharged per 100,000 inhabitants;males;21 Cataract 366 *;patients discharged per 100,000 inhabitants;females;24 Cataract 366 *;Average Stay by patient;both sexes;2 Cataract 366 *;Average Stay by patient;males;2 Cataract 366 *;Average Stay by patient;females;2 Other disorders of the eye & adnexa Rest (360-379) *;patients discharged per 100,000 inhabitants;both sexes;61 Other disorders of the eye & adnexa Rest (360-379) *;patients discharged per 100,000 inhabitants;males;64 Other disorders of the eye & adnexa Rest (360-379) *;patients discharged per 100,000 inhabitants;females;59 Other disorders of the eye & adnexa Rest (360-379) *;Average Stay by patient;both sexes;3 Other disorders of the eye & adnexa Rest (360-379) *;Average Stay by patient;males;3 Other disorders of the eye & adnexa Rest (360-379) *;Average Stay by patient;females;3 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;patients discharged per 100,000 inhabitants;both sexes;55 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;patients discharged per 100,000 inhabitants;males;56 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;patients discharged per 100,000 inhabitants;females;55 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;Average Stay by patient;both sexes;3 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;Average Stay by patient;males;3 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;Average Stay by patient;females;3 Otitis media 381-382 *;patients discharged per 100,000 inhabitants;both sexes;15 Otitis media 381-382 *;patients discharged per 100,000 inhabitants;males;16 Otitis media 381-382 *;patients discharged per 100,000 inhabitants;females;13 Otitis media 381-382 *;Average Stay by patient;both sexes;2 Otitis media 381-382 *;Average Stay by patient;males;2 Otitis media 381-382 *;Average Stay by patient;females;2 Other diseases of the ear Rest (380-389) *;patients discharged per 100,000 inhabitants;both sexes;41 Other diseases of the ear Rest (380-389) *;patients discharged per 100,000 inhabitants;males;39 Other diseases of the ear Rest (380-389) *;patients discharged per 100,000 inhabitants;females;42 Other diseases of the ear Rest (380-389) *;Average Stay by patient;both sexes;3 Other diseases of the ear Rest (380-389) *;Average Stay by patient;males;3 Other diseases of the ear Rest (380-389) *;Average Stay by patient;females;3 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;patients discharged per 100,000 inhabitants;both sexes;1,336 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;patients discharged per 100,000 inhabitants;males;1,512 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;patients discharged per 100,000 inhabitants;females;1,165 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;Average Stay by patient;both sexes;8 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;Average Stay by patient;males;8 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;Average Stay by patient;females;8 ACCUTE RHEUMATIC FEVER 390-392 VII.1;patients discharged per 100,000 inhabitants;both sexes;0 ACCUTE RHEUMATIC FEVER 390-392 VII.1;patients discharged per 100,000 inhabitants;males;0 ACCUTE RHEUMATIC FEVER 390-392 VII.1;patients discharged per 100,000 inhabitants;females;0 ACCUTE RHEUMATIC FEVER 390-392 VII.1;Average Stay by patient;both sexes;14 ACCUTE RHEUMATIC FEVER 390-392 VII.1;Average Stay by patient;males;14 ACCUTE RHEUMATIC FEVER 390-392 VII.1;Average Stay by patient;females;15 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;patients discharged per 100,000 inhabitants;both sexes;17 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;patients discharged per 100,000 inhabitants;males;11 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;patients discharged per 100,000 inhabitants;females;24 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;Average Stay by patient;both sexes;11 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;Average Stay by patient;males;11 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;Average Stay by patient;females;11 HYPERTENSIVE DISEASES 401-405 VII.3;patients discharged per 100,000 inhabitants;both sexes;64 HYPERTENSIVE DISEASES 401-405 VII.3;patients discharged per 100,000 inhabitants;males;56 HYPERTENSIVE DISEASES 401-405 VII.3;patients discharged per 100,000 inhabitants;females;72 HYPERTENSIVE DISEASES 401-405 VII.3;Average Stay by patient;both sexes;8 HYPERTENSIVE DISEASES 401-405 VII.3;Average Stay by patient;males;8 HYPERTENSIVE DISEASES 401-405 VII.3;Average Stay by patient;females;8 ISCHAEMIC CARDIOPATHY 410-414 VII.4;patients discharged per 100,000 inhabitants;both sexes;282 ISCHAEMIC CARDIOPATHY 410-414 VII.4;patients discharged per 100,000 inhabitants;males;405 ISCHAEMIC CARDIOPATHY 410-414 VII.4;patients discharged per 100,000 inhabitants;females;163 ISCHAEMIC CARDIOPATHY 410-414 VII.4;Average Stay by patient;both sexes;7 ISCHAEMIC CARDIOPATHY 410-414 VII.4;Average Stay by patient;males;7 ISCHAEMIC CARDIOPATHY 410-414 VII.4;Average Stay by patient;females;7 Acute myocardial infarction 410;patients discharged per 100,000 inhabitants;both sexes;118 Acute myocardial infarction 410;patients discharged per 100,000 inhabitants;males;169 Acute myocardial infarction 410;patients discharged per 100,000 inhabitants;females;68 Acute myocardial infarction 410;Average Stay by patient;both sexes;8 Acute myocardial infarction 410;Average Stay by patient;males;8 Acute myocardial infarction 410;Average Stay by patient;females;8 Other ischaemic heart diseases 411-412.414 *;patients discharged per 100,000 inhabitants;both sexes;144 Other ischaemic heart diseases 411-412.414 *;patients discharged per 100,000 inhabitants;males;210 Other ischaemic heart diseases 411-412.414 *;patients discharged per 100,000 inhabitants;females;79 Other ischaemic heart diseases 411-412.414 *;Average Stay by patient;both sexes;6 Other ischaemic heart diseases 411-412.414 *;Average Stay by patient;males;6 Other ischaemic heart diseases 411-412.414 *;Average Stay by patient;females;7 Angina pectoris 413 *;patients discharged per 100,000 inhabitants;both sexes;21 Angina pectoris 413 *;patients discharged per 100,000 inhabitants;males;26 Angina pectoris 413 *;patients discharged per 100,000 inhabitants;females;16 Angina pectoris 413 *;Average Stay by patient;both sexes;5 Angina pectoris 413 *;Average Stay by patient;males;5 Angina pectoris 413 *;Average Stay by patient;females;5 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;patients discharged per 100,000 inhabitants;both sexes;39 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;patients discharged per 100,000 inhabitants;males;37 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;patients discharged per 100,000 inhabitants;females;42 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;Average Stay by patient;both sexes;10 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;Average Stay by patient;males;10 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;Average Stay by patient;females;10 OTHER FORMS OF HEART DISEASES 420-429 VII.6;patients discharged per 100,000 inhabitants;both sexes;454 OTHER FORMS OF HEART DISEASES 420-429 VII.6;patients discharged per 100,000 inhabitants;males;469 OTHER FORMS OF HEART DISEASES 420-429 VII.6;patients discharged per 100,000 inhabitants;females;439 OTHER FORMS OF HEART DISEASES 420-429 VII.6;Average Stay by patient;both sexes;8 OTHER FORMS OF HEART DISEASES 420-429 VII.6;Average Stay by patient;males;8 OTHER FORMS OF HEART DISEASES 420-429 VII.6;Average Stay by patient;females;8 Conduction disorders and cardiac dysrhythmias 426-427 *;patients discharged per 100,000 inhabitants;both sexes;155 Conduction disorders and cardiac dysrhythmias 426-427 *;patients discharged per 100,000 inhabitants;males;170 Conduction disorders and cardiac dysrhythmias 426-427 *;patients discharged per 100,000 inhabitants;females;141 Conduction disorders and cardiac dysrhythmias 426-427 *;Average Stay by patient;both sexes;5 Conduction disorders and cardiac dysrhythmias 426-427 *;Average Stay by patient;males;5 Conduction disorders and cardiac dysrhythmias 426-427 *;Average Stay by patient;females;6 Heart failure 428 *;patients discharged per 100,000 inhabitants;both sexes;233 Heart failure 428 *;patients discharged per 100,000 inhabitants;males;217 Heart failure 428 *;patients discharged per 100,000 inhabitants;females;248 Heart failure 428 *;Average Stay by patient;both sexes;9 Heart failure 428 *;Average Stay by patient;males;9 Heart failure 428 *;Average Stay by patient;females;9 Other heart diseases Rest (420-429) *;patients discharged per 100,000 inhabitants;both sexes;65 Other heart diseases Rest (420-429) *;patients discharged per 100,000 inhabitants;males;82 Other heart diseases Rest (420-429) *;patients discharged per 100,000 inhabitants;females;50 Other heart diseases Rest (420-429) *;Average Stay by patient;both sexes;10 Other heart diseases Rest (420-429) *;Average Stay by patient;males;10 Other heart diseases Rest (420-429) *;Average Stay by patient;females;10 CEREBROVASCULAR DISEASES 430-438 VII.7;patients discharged per 100,000 inhabitants;both sexes;255 CEREBROVASCULAR DISEASES 430-438 VII.7;patients discharged per 100,000 inhabitants;males;275 CEREBROVASCULAR DISEASES 430-438 VII.7;patients discharged per 100,000 inhabitants;females;235 CEREBROVASCULAR DISEASES 430-438 VII.7;Average Stay by patient;both sexes;10 CEREBROVASCULAR DISEASES 430-438 VII.7;Average Stay by patient;males;10 CEREBROVASCULAR DISEASES 430-438 VII.7;Average Stay by patient;females;11 Transient cerebral ischemia 435 *;patients discharged per 100,000 inhabitants;both sexes;33 Transient cerebral ischemia 435 *;patients discharged per 100,000 inhabitants;males;34 Transient cerebral ischemia 435 *;patients discharged per 100,000 inhabitants;females;32 Transient cerebral ischemia 435 *;Average Stay by patient;both sexes;6 Transient cerebral ischemia 435 *;Average Stay by patient;males;6 Transient cerebral ischemia 435 *;Average Stay by patient;females;6 Other cerebrovascular diseases Rest (430-438) *;patients discharged per 100,000 inhabitants;both sexes;222 Other cerebrovascular diseases Rest (430-438) *;patients discharged per 100,000 inhabitants;males;241 Other cerebrovascular diseases Rest (430-438) *;patients discharged per 100,000 inhabitants;females;203 Other cerebrovascular diseases Rest (430-438) *;Average Stay by patient;both sexes;11 Other cerebrovascular diseases Rest (430-438) *;Average Stay by patient;males;11 Other cerebrovascular diseases Rest (430-438) *;Average Stay by patient;females;11 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;patients discharged per 100,000 inhabitants;both sexes;84 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;patients discharged per 100,000 inhabitants;males;125 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;patients discharged per 100,000 inhabitants;females;45 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;Average Stay by patient;both sexes;11 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;Average Stay by patient;males;11 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;Average Stay by patient;females;11 Atherosclerosis 440 *;patients discharged per 100,000 inhabitants;both sexes;39 Atherosclerosis 440 *;patients discharged per 100,000 inhabitants;males;59 Atherosclerosis 440 *;patients discharged per 100,000 inhabitants;females;19 Atherosclerosis 440 *;Average Stay by patient;both sexes;12 Atherosclerosis 440 *;Average Stay by patient;males;12 Atherosclerosis 440 *;Average Stay by patient;females;13 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;patients discharged per 100,000 inhabitants;both sexes;46 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;patients discharged per 100,000 inhabitants;males;66 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;patients discharged per 100,000 inhabitants;females;26 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;Average Stay by patient;both sexes;10 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;Average Stay by patient;males;10 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;Average Stay by patient;females;9 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;patients discharged per 100,000 inhabitants;both sexes;140 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;patients discharged per 100,000 inhabitants;males;134 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;patients discharged per 100,000 inhabitants;females;145 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;Average Stay by patient;both sexes;3 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;Average Stay by patient;males;3 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;Average Stay by patient;females;3 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;patients discharged per 100,000 inhabitants;both sexes;27 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;patients discharged per 100,000 inhabitants;males;28 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;patients discharged per 100,000 inhabitants;females;26 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;Average Stay by patient;both sexes;7 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;Average Stay by patient;males;7 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;Average Stay by patient;females;7 Varicose veins of lower extremities 454;patients discharged per 100,000 inhabitants;both sexes;51 Varicose veins of lower extremities 454;patients discharged per 100,000 inhabitants;males;35 Varicose veins of lower extremities 454;patients discharged per 100,000 inhabitants;females;67 Varicose veins of lower extremities 454;Average Stay by patient;both sexes;2 Varicose veins of lower extremities 454;Average Stay by patient;males;2 Varicose veins of lower extremities 454;Average Stay by patient;females;2 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);patients discharged per 100,000 inhabitants;both sexes;61 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);patients discharged per 100,000 inhabitants;males;70 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);patients discharged per 100,000 inhabitants;females;52 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);Average Stay by patient;both sexes;3 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);Average Stay by patient;males;3 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);Average Stay by patient;females;3 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;patients discharged per 100,000 inhabitants;both sexes;1,099 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;patients discharged per 100,000 inhabitants;males;1,315 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;patients discharged per 100,000 inhabitants;females;890 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;Average Stay by patient;both sexes;7 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;Average Stay by patient;males;7 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;Average Stay by patient;females;7 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;patients discharged per 100,000 inhabitants;both sexes;292 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;patients discharged per 100,000 inhabitants;males;330 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;patients discharged per 100,000 inhabitants;females;255 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;Average Stay by patient;both sexes;3 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;Average Stay by patient;males;3 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;Average Stay by patient;females;3 Bronchitis and acute bronchiolitis 466;patients discharged per 100,000 inhabitants;both sexes;97 Bronchitis and acute bronchiolitis 466;patients discharged per 100,000 inhabitants;males;101 Bronchitis and acute bronchiolitis 466;patients discharged per 100,000 inhabitants;females;92 Bronchitis and acute bronchiolitis 466;Average Stay by patient;both sexes;5 Bronchitis and acute bronchiolitis 466;Average Stay by patient;males;5 Bronchitis and acute bronchiolitis 466;Average Stay by patient;females;6 Chronic diseases of the amygdalas and adenoid vegetations 474;patients discharged per 100,000 inhabitants;both sexes;62 Chronic diseases of the amygdalas and adenoid vegetations 474;patients discharged per 100,000 inhabitants;males;67 Chronic diseases of the amygdalas and adenoid vegetations 474;patients discharged per 100,000 inhabitants;females;58 Chronic diseases of the amygdalas and adenoid vegetations 474;Average Stay by patient;both sexes;1 Chronic diseases of the amygdalas and adenoid vegetations 474;Average Stay by patient;males;1 Chronic diseases of the amygdalas and adenoid vegetations 474;Average Stay by patient;females;1 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);patients discharged per 100,000 inhabitants;both sexes;133 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);patients discharged per 100,000 inhabitants;males;163 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);patients discharged per 100,000 inhabitants;females;105 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);Average Stay by patient;both sexes;2 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);Average Stay by patient;males;2 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);Average Stay by patient;females;2 PNEUMONIA AND INFLUENZA 480-488 VIII.2;patients discharged per 100,000 inhabitants;both sexes;239 PNEUMONIA AND INFLUENZA 480-488 VIII.2;patients discharged per 100,000 inhabitants;males;291 PNEUMONIA AND INFLUENZA 480-488 VIII.2;patients discharged per 100,000 inhabitants;females;189 PNEUMONIA AND INFLUENZA 480-488 VIII.2;Average Stay by patient;both sexes;8 PNEUMONIA AND INFLUENZA 480-488 VIII.2;Average Stay by patient;males;9 PNEUMONIA AND INFLUENZA 480-488 VIII.2;Average Stay by patient;females;8 Pneumonia 480-486 *;patients discharged per 100,000 inhabitants;both sexes;237 Pneumonia 480-486 *;patients discharged per 100,000 inhabitants;males;289 Pneumonia 480-486 *;patients discharged per 100,000 inhabitants;females;187 Pneumonia 480-486 *;Average Stay by patient;both sexes;8 Pneumonia 480-486 *;Average Stay by patient;males;9 Pneumonia 480-486 *;Average Stay by patient;females;8 Flu 487-488 *;patients discharged per 100,000 inhabitants;both sexes;2 Flu 487-488 *;patients discharged per 100,000 inhabitants;males;3 Flu 487-488 *;patients discharged per 100,000 inhabitants;females;2 Flu 487-488 *;Average Stay by patient;both sexes;13 Flu 487-488 *;Average Stay by patient;males;14 Flu 487-488 *;Average Stay by patient;females;13 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;patients discharged per 100,000 inhabitants;both sexes;223 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;patients discharged per 100,000 inhabitants;males;312 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;patients discharged per 100,000 inhabitants;females;136 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;Average Stay by patient;both sexes;8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;Average Stay by patient;males;8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;Average Stay by patient;females;7 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;patients discharged per 100,000 inhabitants;both sexes;169 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;patients discharged per 100,000 inhabitants;males;274 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;patients discharged per 100,000 inhabitants;females;67 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;Average Stay by patient;both sexes;8 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;Average Stay by patient;males;8 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;Average Stay by patient;females;9 Asthma 493 *;patients discharged per 100,000 inhabitants;both sexes;53 Asthma 493 *;patients discharged per 100,000 inhabitants;males;37 Asthma 493 *;patients discharged per 100,000 inhabitants;females;69 Asthma 493 *;Average Stay by patient;both sexes;6 Asthma 493 *;Average Stay by patient;males;4 Asthma 493 *;Average Stay by patient;females;6 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);patients discharged per 100,000 inhabitants;both sexes;0 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);patients discharged per 100,000 inhabitants;males;0 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);patients discharged per 100,000 inhabitants;females;0 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);Average Stay by patient;both sexes;10 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);Average Stay by patient;males;9 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);Average Stay by patient;females;10 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;patients discharged per 100,000 inhabitants;both sexes;345 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;patients discharged per 100,000 inhabitants;males;381 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;patients discharged per 100,000 inhabitants;females;310 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;Average Stay by patient;both sexes;9 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;Average Stay by patient;males;9 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;Average Stay by patient;females;9 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;patients discharged per 100,000 inhabitants;both sexes;1,239 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;patients discharged per 100,000 inhabitants;males;1,408 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;patients discharged per 100,000 inhabitants;females;1,075 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;Average Stay by patient;both sexes;6 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;Average Stay by patient;males;6 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;Average Stay by patient;females;6 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;patients discharged per 100,000 inhabitants;both sexes;46 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;patients discharged per 100,000 inhabitants;males;48 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;patients discharged per 100,000 inhabitants;females;45 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;Average Stay by patient;both sexes;3 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;Average Stay by patient;males;3 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;Average Stay by patient;females;3 Disorders of the teeth and supporting structures 520-525 *;patients discharged per 100,000 inhabitants;both sexes;29 Disorders of the teeth and supporting structures 520-525 *;patients discharged per 100,000 inhabitants;males;27 Disorders of the teeth and supporting structures 520-525 *;patients discharged per 100,000 inhabitants;females;31 Disorders of the teeth and supporting structures 520-525 *;Average Stay by patient;both sexes;2 Disorders of the teeth and supporting structures 520-525 *;Average Stay by patient;males;2 Disorders of the teeth and supporting structures 520-525 *;Average Stay by patient;females;2 Diseases of the oral cavity, salivary glands and jaws 526-529 *;patients discharged per 100,000 inhabitants;both sexes;17 Diseases of the oral cavity, salivary glands and jaws 526-529 *;patients discharged per 100,000 inhabitants;males;20 Diseases of the oral cavity, salivary glands and jaws 526-529 *;patients discharged per 100,000 inhabitants;females;15 Diseases of the oral cavity, salivary glands and jaws 526-529 *;Average Stay by patient;both sexes;4 Diseases of the oral cavity, salivary glands and jaws 526-529 *;Average Stay by patient;males;4 Diseases of the oral cavity, salivary glands and jaws 526-529 *;Average Stay by patient;females;4 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;patients discharged per 100,000 inhabitants;both sexes;80 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;patients discharged per 100,000 inhabitants;males;97 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;patients discharged per 100,000 inhabitants;females;63 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;Average Stay by patient;both sexes;6 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;Average Stay by patient;males;6 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;Average Stay by patient;females;6 Diseases of esophagus 530 *;patients discharged per 100,000 inhabitants;both sexes;24 Diseases of esophagus 530 *;patients discharged per 100,000 inhabitants;males;31 Diseases of esophagus 530 *;patients discharged per 100,000 inhabitants;females;18 Diseases of esophagus 530 *;Average Stay by patient;both sexes;5 Diseases of esophagus 530 *;Average Stay by patient;males;5 Diseases of esophagus 530 *;Average Stay by patient;females;6 Ulcers 531-534 *;patients discharged per 100,000 inhabitants;both sexes;25 Ulcers 531-534 *;patients discharged per 100,000 inhabitants;males;35 Ulcers 531-534 *;patients discharged per 100,000 inhabitants;females;15 Ulcers 531-534 *;Average Stay by patient;both sexes;8 Ulcers 531-534 *;Average Stay by patient;males;7 Ulcers 531-534 *;Average Stay by patient;females;8 Gastritis and other diseases of the stomach and duodenum 535-538 *;patients discharged per 100,000 inhabitants;both sexes;31 Gastritis and other diseases of the stomach and duodenum 535-538 *;patients discharged per 100,000 inhabitants;males;32 Gastritis and other diseases of the stomach and duodenum 535-538 *;patients discharged per 100,000 inhabitants;females;30 Gastritis and other diseases of the stomach and duodenum 535-538 *;Average Stay by patient;both sexes;6 Gastritis and other diseases of the stomach and duodenum 535-538 *;Average Stay by patient;males;6 Gastritis and other diseases of the stomach and duodenum 535-538 *;Average Stay by patient;females;6 APPENDICITIS 540-543 IX.3;patients discharged per 100,000 inhabitants;both sexes;108 APPENDICITIS 540-543 IX.3;patients discharged per 100,000 inhabitants;males;126 APPENDICITIS 540-543 IX.3;patients discharged per 100,000 inhabitants;females;92 APPENDICITIS 540-543 IX.3;Average Stay by patient;both sexes;4 APPENDICITIS 540-543 IX.3;Average Stay by patient;males;4 APPENDICITIS 540-543 IX.3;Average Stay by patient;females;4 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;patients discharged per 100,000 inhabitants;both sexes;235 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;patients discharged per 100,000 inhabitants;males;338 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;patients discharged per 100,000 inhabitants;females;136 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;Average Stay by patient;both sexes;3 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;Average Stay by patient;males;2 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;Average Stay by patient;females;4 Inguinal hernia 550 *;patients discharged per 100,000 inhabitants;both sexes;136 Inguinal hernia 550 *;patients discharged per 100,000 inhabitants;males;242 Inguinal hernia 550 *;patients discharged per 100,000 inhabitants;females;32 Inguinal hernia 550 *;Average Stay by patient;both sexes;2 Inguinal hernia 550 *;Average Stay by patient;males;2 Inguinal hernia 550 *;Average Stay by patient;females;2 Other hernia of abdominal cavity 551-553 *;patients discharged per 100,000 inhabitants;both sexes;100 Other hernia of abdominal cavity 551-553 *;patients discharged per 100,000 inhabitants;males;96 Other hernia of abdominal cavity 551-553 *;patients discharged per 100,000 inhabitants;females;104 Other hernia of abdominal cavity 551-553 *;Average Stay by patient;both sexes;4 Other hernia of abdominal cavity 551-553 *;Average Stay by patient;males;3 Other hernia of abdominal cavity 551-553 *;Average Stay by patient;females;4 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;patients discharged per 100,000 inhabitants;both sexes;329 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;patients discharged per 100,000 inhabitants;males;351 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;patients discharged per 100,000 inhabitants;females;308 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;Average Stay by patient;both sexes;7 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;Average Stay by patient;males;6 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;Average Stay by patient;females;7 Regional enteritis and Crohn's disease 555-556 *;patients discharged per 100,000 inhabitants;both sexes;24 Regional enteritis and Crohn's disease 555-556 *;patients discharged per 100,000 inhabitants;males;25 Regional enteritis and Crohn's disease 555-556 *;patients discharged per 100,000 inhabitants;females;23 Regional enteritis and Crohn's disease 555-556 *;Average Stay by patient;both sexes;10 Regional enteritis and Crohn's disease 555-556 *;Average Stay by patient;males;10 Regional enteritis and Crohn's disease 555-556 *;Average Stay by patient;females;10 Other noninfectious gastroenteritis and colitis 558 *;patients discharged per 100,000 inhabitants;both sexes;79 Other noninfectious gastroenteritis and colitis 558 *;patients discharged per 100,000 inhabitants;males;75 Other noninfectious gastroenteritis and colitis 558 *;patients discharged per 100,000 inhabitants;females;82 Other noninfectious gastroenteritis and colitis 558 *;Average Stay by patient;both sexes;4 Other noninfectious gastroenteritis and colitis 558 *;Average Stay by patient;males;4 Other noninfectious gastroenteritis and colitis 558 *;Average Stay by patient;females;4 Intestinal obstruction without mention of hernia 560 *;patients discharged per 100,000 inhabitants;both sexes;56 Intestinal obstruction without mention of hernia 560 *;patients discharged per 100,000 inhabitants;males;58 Intestinal obstruction without mention of hernia 560 *;patients discharged per 100,000 inhabitants;females;53 Intestinal obstruction without mention of hernia 560 *;Average Stay by patient;both sexes;9 Intestinal obstruction without mention of hernia 560 *;Average Stay by patient;males;9 Intestinal obstruction without mention of hernia 560 *;Average Stay by patient;females;9 Diverticula of intestine 562 *;patients discharged per 100,000 inhabitants;both sexes;42 Diverticula of intestine 562 *;patients discharged per 100,000 inhabitants;males;42 Diverticula of intestine 562 *;patients discharged per 100,000 inhabitants;females;42 Diverticula of intestine 562 *;Average Stay by patient;both sexes;8 Diverticula of intestine 562 *;Average Stay by patient;males;8 Diverticula of intestine 562 *;Average Stay by patient;females;8 Other disorders of intestine and peritoneum Rest (555-569) *;patients discharged per 100,000 inhabitants;both sexes;129 Other disorders of intestine and peritoneum Rest (555-569) *;patients discharged per 100,000 inhabitants;males;151 Other disorders of intestine and peritoneum Rest (555-569) *;patients discharged per 100,000 inhabitants;females;107 Other disorders of intestine and peritoneum Rest (555-569) *;Average Stay by patient;both sexes;6 Other disorders of intestine and peritoneum Rest (555-569) *;Average Stay by patient;males;6 Other disorders of intestine and peritoneum Rest (555-569) *;Average Stay by patient;females;6 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;patients discharged per 100,000 inhabitants;both sexes;440 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;patients discharged per 100,000 inhabitants;males;450 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;patients discharged per 100,000 inhabitants;females;431 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;Average Stay by patient;both sexes;7 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;Average Stay by patient;males;8 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;Average Stay by patient;females;7 Diseases of liver and chronic cirrhosis of liver 571;patients discharged per 100,000 inhabitants;both sexes;43 Diseases of liver and chronic cirrhosis of liver 571;patients discharged per 100,000 inhabitants;males;62 Diseases of liver and chronic cirrhosis of liver 571;patients discharged per 100,000 inhabitants;females;25 Diseases of liver and chronic cirrhosis of liver 571;Average Stay by patient;both sexes;10 Diseases of liver and chronic cirrhosis of liver 571;Average Stay by patient;males;10 Diseases of liver and chronic cirrhosis of liver 571;Average Stay by patient;females;9 Cholelithiasis 574 *;patients discharged per 100,000 inhabitants;both sexes;214 Cholelithiasis 574 *;patients discharged per 100,000 inhabitants;males;179 Cholelithiasis 574 *;patients discharged per 100,000 inhabitants;females;248 Cholelithiasis 574 *;Average Stay by patient;both sexes;5 Cholelithiasis 574 *;Average Stay by patient;males;6 Cholelithiasis 574 *;Average Stay by patient;females;5 Other disorders of gallbladder and biliary tract 575-576 *;patients discharged per 100,000 inhabitants;both sexes;55 Other disorders of gallbladder and biliary tract 575-576 *;patients discharged per 100,000 inhabitants;males;59 Other disorders of gallbladder and biliary tract 575-576 *;patients discharged per 100,000 inhabitants;females;51 Other disorders of gallbladder and biliary tract 575-576 *;Average Stay by patient;both sexes;8 Other disorders of gallbladder and biliary tract 575-576 *;Average Stay by patient;males;9 Other disorders of gallbladder and biliary tract 575-576 *;Average Stay by patient;females;8 Diseases of pancreas 577 *;patients discharged per 100,000 inhabitants;both sexes;63 Diseases of pancreas 577 *;patients discharged per 100,000 inhabitants;males;72 Diseases of pancreas 577 *;patients discharged per 100,000 inhabitants;females;55 Diseases of pancreas 577 *;Average Stay by patient;both sexes;10 Diseases of pancreas 577 *;Average Stay by patient;males;10 Diseases of pancreas 577 *;Average Stay by patient;females;10 Other Diseases of the Digestive System Rest (570-579);patients discharged per 100,000 inhabitants;both sexes;65 Other Diseases of the Digestive System Rest (570-579);patients discharged per 100,000 inhabitants;males;78 Other Diseases of the Digestive System Rest (570-579);patients discharged per 100,000 inhabitants;females;52 Other Diseases of the Digestive System Rest (570-579);Average Stay by patient;both sexes;8 Other Diseases of the Digestive System Rest (570-579);Average Stay by patient;males;8 Other Diseases of the Digestive System Rest (570-579);Average Stay by patient;females;8 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;patients discharged per 100,000 inhabitants;both sexes;628 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;patients discharged per 100,000 inhabitants;males;571 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;patients discharged per 100,000 inhabitants;females;682 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;Average Stay by patient;both sexes;5 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;Average Stay by patient;males;5 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;Average Stay by patient;females;5 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;patients discharged per 100,000 inhabitants;both sexes;56 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;patients discharged per 100,000 inhabitants;males;66 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;patients discharged per 100,000 inhabitants;females;47 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;Average Stay by patient;both sexes;9 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;Average Stay by patient;males;9 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;Average Stay by patient;females;9 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;patients discharged per 100,000 inhabitants;both sexes;268 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;patients discharged per 100,000 inhabitants;males;286 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;patients discharged per 100,000 inhabitants;females;250 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;Average Stay by patient;both sexes;6 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;Average Stay by patient;males;6 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;Average Stay by patient;females;6 Urinary calculus 592.594;patients discharged per 100,000 inhabitants;both sexes;53 Urinary calculus 592.594;patients discharged per 100,000 inhabitants;males;65 Urinary calculus 592.594;patients discharged per 100,000 inhabitants;females;41 Urinary calculus 592.594;Average Stay by patient;both sexes;4 Urinary calculus 592.594;Average Stay by patient;males;4 Urinary calculus 592.594;Average Stay by patient;females;4 Other diseases of the urinary system Rest (590-599);patients discharged per 100,000 inhabitants;both sexes;215 Other diseases of the urinary system Rest (590-599);patients discharged per 100,000 inhabitants;males;221 Other diseases of the urinary system Rest (590-599);patients discharged per 100,000 inhabitants;females;209 Other diseases of the urinary system Rest (590-599);Average Stay by patient;both sexes;6 Other diseases of the urinary system Rest (590-599);Average Stay by patient;males;6 Other diseases of the urinary system Rest (590-599);Average Stay by patient;females;6 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;patients discharged per 100,000 inhabitants;both sexes;104 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;patients discharged per 100,000 inhabitants;males;210 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;patients discharged per 100,000 inhabitants;females;.. OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;Average Stay by patient;both sexes;4 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;Average Stay by patient;males;4 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;Average Stay by patient;females;.. Hyperplasia of prostate 600;patients discharged per 100,000 inhabitants;both sexes;55 Hyperplasia of prostate 600;patients discharged per 100,000 inhabitants;males;111 Hyperplasia of prostate 600;patients discharged per 100,000 inhabitants;females;.. Hyperplasia of prostate 600;Average Stay by patient;both sexes;5 Hyperplasia of prostate 600;Average Stay by patient;males;5 Hyperplasia of prostate 600;Average Stay by patient;females;.. Other male genital organs diseases (600-608), Rest;patients discharged per 100,000 inhabitants;both sexes;49 Other male genital organs diseases (600-608), Rest;patients discharged per 100,000 inhabitants;males;99 Other male genital organs diseases (600-608), Rest;patients discharged per 100,000 inhabitants;females;.. Other male genital organs diseases (600-608), Rest;Average Stay by patient;both sexes;3 Other male genital organs diseases (600-608), Rest;Average Stay by patient;males;3 Other male genital organs diseases (600-608), Rest;Average Stay by patient;females;.. BREAST DISORDERS 610-612 X.4;patients discharged per 100,000 inhabitants;both sexes;37 BREAST DISORDERS 610-612 X.4;patients discharged per 100,000 inhabitants;males;9 BREAST DISORDERS 610-612 X.4;patients discharged per 100,000 inhabitants;females;64 BREAST DISORDERS 610-612 X.4;Average Stay by patient;both sexes;2 BREAST DISORDERS 610-612 X.4;Average Stay by patient;males;2 BREAST DISORDERS 610-612 X.4;Average Stay by patient;females;2 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;patients discharged per 100,000 inhabitants;both sexes;163 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;patients discharged per 100,000 inhabitants;males;.. DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;patients discharged per 100,000 inhabitants;females;321 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;Average Stay by patient;both sexes;3 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;Average Stay by patient;males;.. DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;Average Stay by patient;females;3 Inflammatory diseases of female pelvic organs 614-616 *;patients discharged per 100,000 inhabitants;both sexes;19 Inflammatory diseases of female pelvic organs 614-616 *;patients discharged per 100,000 inhabitants;males;.. Inflammatory diseases of female pelvic organs 614-616 *;patients discharged per 100,000 inhabitants;females;38 Inflammatory diseases of female pelvic organs 614-616 *;Average Stay by patient;both sexes;4 Inflammatory diseases of female pelvic organs 614-616 *;Average Stay by patient;males;.. Inflammatory diseases of female pelvic organs 614-616 *;Average Stay by patient;females;4 Other diseases of the female pelvic and genital organs Rest (614-629);patients discharged per 100,000 inhabitants;both sexes;143 Other diseases of the female pelvic and genital organs Rest (614-629);patients discharged per 100,000 inhabitants;males;.. Other diseases of the female pelvic and genital organs Rest (614-629);patients discharged per 100,000 inhabitants;females;283 Other diseases of the female pelvic and genital organs Rest (614-629);Average Stay by patient;both sexes;3 Other diseases of the female pelvic and genital organs Rest (614-629);Average Stay by patient;males;.. Other diseases of the female pelvic and genital organs Rest (614-629);Average Stay by patient;females;3 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;patients discharged per 100,000 inhabitants;both sexes;1,259 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;patients discharged per 100,000 inhabitants;males;.. COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;patients discharged per 100,000 inhabitants;females;2,481 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;Average Stay by patient;both sexes;3 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;Average Stay by patient;males;.. COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;Average Stay by patient;females;3 ABORTION 630-639 XI.1;patients discharged per 100,000 inhabitants;both sexes;102 ABORTION 630-639 XI.1;patients discharged per 100,000 inhabitants;males;.. ABORTION 630-639 XI.1;patients discharged per 100,000 inhabitants;females;201 ABORTION 630-639 XI.1;Average Stay by patient;both sexes;2 ABORTION 630-639 XI.1;Average Stay by patient;males;.. ABORTION 630-639 XI.1;Average Stay by patient;females;2 Legally induced abortion 635 *;patients discharged per 100,000 inhabitants;both sexes;6 Legally induced abortion 635 *;patients discharged per 100,000 inhabitants;males;.. Legally induced abortion 635 *;patients discharged per 100,000 inhabitants;females;11 Legally induced abortion 635 *;Average Stay by patient;both sexes;2 Legally induced abortion 635 *;Average Stay by patient;males;.. Legally induced abortion 635 *;Average Stay by patient;females;2 Other pregnancies ending in abortion Rest (630-639) *;patients discharged per 100,000 inhabitants;both sexes;97 Other pregnancies ending in abortion Rest (630-639) *;patients discharged per 100,000 inhabitants;males;.. Other pregnancies ending in abortion Rest (630-639) *;patients discharged per 100,000 inhabitants;females;191 Other pregnancies ending in abortion Rest (630-639) *;Average Stay by patient;both sexes;2 Other pregnancies ending in abortion Rest (630-639) *;Average Stay by patient;males;.. Other pregnancies ending in abortion Rest (630-639) *;Average Stay by patient;females;2 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;patients discharged per 100,000 inhabitants;both sexes;357 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;patients discharged per 100,000 inhabitants;males;.. COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;patients discharged per 100,000 inhabitants;females;703 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;Average Stay by patient;both sexes;3 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;Average Stay by patient;males;.. COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;Average Stay by patient;females;3 NORMAL BIRTH 650 XI.3;patients discharged per 100,000 inhabitants;both sexes;129 NORMAL BIRTH 650 XI.3;patients discharged per 100,000 inhabitants;males;.. NORMAL BIRTH 650 XI.3;patients discharged per 100,000 inhabitants;females;255 NORMAL BIRTH 650 XI.3;Average Stay by patient;both sexes;3 NORMAL BIRTH 650 XI.3;Average Stay by patient;males;.. NORMAL BIRTH 650 XI.3;Average Stay by patient;females;3 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;patients discharged per 100,000 inhabitants;both sexes;393 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;patients discharged per 100,000 inhabitants;males;.. CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;patients discharged per 100,000 inhabitants;females;774 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;Average Stay by patient;both sexes;3 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;Average Stay by patient;males;.. CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;Average Stay by patient;females;3 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;patients discharged per 100,000 inhabitants;both sexes;268 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;patients discharged per 100,000 inhabitants;males;.. COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;patients discharged per 100,000 inhabitants;females;528 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;Average Stay by patient;both sexes;3 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;Average Stay by patient;males;.. COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;Average Stay by patient;females;3 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;patients discharged per 100,000 inhabitants;both sexes;10 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;patients discharged per 100,000 inhabitants;males;.. COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;patients discharged per 100,000 inhabitants;females;19 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;Average Stay by patient;both sexes;4 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;Average Stay by patient;males;.. COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;Average Stay by patient;females;4 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;patients discharged per 100,000 inhabitants;both sexes;106 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;patients discharged per 100,000 inhabitants;males;118 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;patients discharged per 100,000 inhabitants;females;95 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;Average Stay by patient;both sexes;8 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;Average Stay by patient;males;7 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;Average Stay by patient;females;9 Infections of skin and subcutaneous cellular tissue 680-686 *;patients discharged per 100,000 inhabitants;both sexes;64 Infections of skin and subcutaneous cellular tissue 680-686 *;patients discharged per 100,000 inhabitants;males;77 Infections of skin and subcutaneous cellular tissue 680-686 *;patients discharged per 100,000 inhabitants;females;50 Infections of skin and subcutaneous cellular tissue 680-686 *;Average Stay by patient;both sexes;6 Infections of skin and subcutaneous cellular tissue 680-686 *;Average Stay by patient;males;5 Infections of skin and subcutaneous cellular tissue 680-686 *;Average Stay by patient;females;7 Other diseases of skin and subcutaneous tissue Rest (680-709) *;patients discharged per 100,000 inhabitants;both sexes;43 Other diseases of skin and subcutaneous tissue Rest (680-709) *;patients discharged per 100,000 inhabitants;males;40 Other diseases of skin and subcutaneous tissue Rest (680-709) *;patients discharged per 100,000 inhabitants;females;45 Other diseases of skin and subcutaneous tissue Rest (680-709) *;Average Stay by patient;both sexes;11 Other diseases of skin and subcutaneous tissue Rest (680-709) *;Average Stay by patient;males;11 Other diseases of skin and subcutaneous tissue Rest (680-709) *;Average Stay by patient;females;11 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;patients discharged per 100,000 inhabitants;both sexes;735 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;patients discharged per 100,000 inhabitants;males;702 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;patients discharged per 100,000 inhabitants;females;766 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;Average Stay by patient;both sexes;5 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;Average Stay by patient;males;4 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;Average Stay by patient;females;5 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;patients discharged per 100,000 inhabitants;both sexes;379 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;patients discharged per 100,000 inhabitants;males;374 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;patients discharged per 100,000 inhabitants;females;384 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;Average Stay by patient;both sexes;5 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;Average Stay by patient;males;4 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;Average Stay by patient;females;6 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;patients discharged per 100,000 inhabitants;both sexes;5 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;patients discharged per 100,000 inhabitants;males;3 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;patients discharged per 100,000 inhabitants;females;6 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;Average Stay by patient;both sexes;9 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;Average Stay by patient;males;9 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;Average Stay by patient;females;8 Internal derangement of knee 717 *;patients discharged per 100,000 inhabitants;both sexes;113 Internal derangement of knee 717 *;patients discharged per 100,000 inhabitants;males;153 Internal derangement of knee 717 *;patients discharged per 100,000 inhabitants;females;75 Internal derangement of knee 717 *;Average Stay by patient;both sexes;2 Internal derangement of knee 717 *;Average Stay by patient;males;2 Internal derangement of knee 717 *;Average Stay by patient;females;2 Other arthropathies and related disorders Rest (710-719);patients discharged per 100,000 inhabitants;both sexes;261 Other arthropathies and related disorders Rest (710-719);patients discharged per 100,000 inhabitants;males;218 Other arthropathies and related disorders Rest (710-719);patients discharged per 100,000 inhabitants;females;303 Other arthropathies and related disorders Rest (710-719);Average Stay by patient;both sexes;6 Other arthropathies and related disorders Rest (710-719);Average Stay by patient;males;6 Other arthropathies and related disorders Rest (710-719);Average Stay by patient;females;7 DORSOPATHIES 720-724 XIII.2;patients discharged per 100,000 inhabitants;both sexes;121 DORSOPATHIES 720-724 XIII.2;patients discharged per 100,000 inhabitants;males;125 DORSOPATHIES 720-724 XIII.2;patients discharged per 100,000 inhabitants;females;118 DORSOPATHIES 720-724 XIII.2;Average Stay by patient;both sexes;6 DORSOPATHIES 720-724 XIII.2;Average Stay by patient;males;6 DORSOPATHIES 720-724 XIII.2;Average Stay by patient;females;6 Intervertebral disc disorders 722 *;patients discharged per 100,000 inhabitants;both sexes;67 Intervertebral disc disorders 722 *;patients discharged per 100,000 inhabitants;males;73 Intervertebral disc disorders 722 *;patients discharged per 100,000 inhabitants;females;62 Intervertebral disc disorders 722 *;Average Stay by patient;both sexes;6 Intervertebral disc disorders 722 *;Average Stay by patient;males;6 Intervertebral disc disorders 722 *;Average Stay by patient;females;6 Other back disorders Rest (720-724) *;patients discharged per 100,000 inhabitants;both sexes;54 Other back disorders Rest (720-724) *;patients discharged per 100,000 inhabitants;males;53 Other back disorders Rest (720-724) *;patients discharged per 100,000 inhabitants;females;55 Other back disorders Rest (720-724) *;Average Stay by patient;both sexes;6 Other back disorders Rest (720-724) *;Average Stay by patient;males;6 Other back disorders Rest (720-724) *;Average Stay by patient;females;6 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;patients discharged per 100,000 inhabitants;both sexes;110 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;patients discharged per 100,000 inhabitants;males;115 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;patients discharged per 100,000 inhabitants;females;106 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;Average Stay by patient;both sexes;3 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;Average Stay by patient;males;3 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;Average Stay by patient;females;3 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;patients discharged per 100,000 inhabitants;both sexes;124 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;patients discharged per 100,000 inhabitants;males;88 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;patients discharged per 100,000 inhabitants;females;158 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;Average Stay by patient;both sexes;5 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;Average Stay by patient;males;6 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;Average Stay by patient;females;4 Deformations of the limbs 734-736;patients discharged per 100,000 inhabitants;both sexes;61 Deformations of the limbs 734-736;patients discharged per 100,000 inhabitants;males;23 Deformations of the limbs 734-736;patients discharged per 100,000 inhabitants;females;99 Deformations of the limbs 734-736;Average Stay by patient;both sexes;2 Deformations of the limbs 734-736;Average Stay by patient;males;3 Deformations of the limbs 734-736;Average Stay by patient;females;2 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);patients discharged per 100,000 inhabitants;both sexes;62 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);patients discharged per 100,000 inhabitants;males;65 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);patients discharged per 100,000 inhabitants;females;60 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);Average Stay by patient;both sexes;7 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);Average Stay by patient;males;7 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);Average Stay by patient;females;8 CONGENITAL ABNORMALITIES 740-759 XIV;patients discharged per 100,000 inhabitants;both sexes;95 CONGENITAL ABNORMALITIES 740-759 XIV;patients discharged per 100,000 inhabitants;males;104 CONGENITAL ABNORMALITIES 740-759 XIV;patients discharged per 100,000 inhabitants;females;87 CONGENITAL ABNORMALITIES 740-759 XIV;Average Stay by patient;both sexes;5 CONGENITAL ABNORMALITIES 740-759 XIV;Average Stay by patient;males;5 CONGENITAL ABNORMALITIES 740-759 XIV;Average Stay by patient;females;4 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;patients discharged per 100,000 inhabitants;both sexes;153 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;patients discharged per 100,000 inhabitants;males;171 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;patients discharged per 100,000 inhabitants;females;136 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;Average Stay by patient;both sexes;9 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;Average Stay by patient;males;9 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;Average Stay by patient;females;9 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;patients discharged per 100,000 inhabitants;both sexes;12 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;patients discharged per 100,000 inhabitants;males;12 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;patients discharged per 100,000 inhabitants;females;12 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;Average Stay by patient;both sexes;3 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;Average Stay by patient;males;3 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;Average Stay by patient;females;3 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;patients discharged per 100,000 inhabitants;both sexes;142 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;patients discharged per 100,000 inhabitants;males;159 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;patients discharged per 100,000 inhabitants;females;124 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;Average Stay by patient;both sexes;9 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;Average Stay by patient;males;9 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;Average Stay by patient;females;10 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;patients discharged per 100,000 inhabitants;both sexes;53 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;patients discharged per 100,000 inhabitants;males;55 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;patients discharged per 100,000 inhabitants;females;50 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;Average Stay by patient;both sexes;17 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;Average Stay by patient;males;17 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;Average Stay by patient;females;17 Other diseases originated in the perinatal period Rest (764-779);patients discharged per 100,000 inhabitants;both sexes;89 Other diseases originated in the perinatal period Rest (764-779);patients discharged per 100,000 inhabitants;males;104 Other diseases originated in the perinatal period Rest (764-779);patients discharged per 100,000 inhabitants;females;74 Other diseases originated in the perinatal period Rest (764-779);Average Stay by patient;both sexes;5 Other diseases originated in the perinatal period Rest (764-779);Average Stay by patient;males;5 Other diseases originated in the perinatal period Rest (764-779);Average Stay by patient;females;5 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;patients discharged per 100,000 inhabitants;both sexes;435 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;patients discharged per 100,000 inhabitants;males;469 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;patients discharged per 100,000 inhabitants;females;401 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;Average Stay by patient;both sexes;5 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;Average Stay by patient;males;5 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;Average Stay by patient;females;5 INJURIES AND POISONING 800-999 XVII;patients discharged per 100,000 inhabitants;both sexes;884 INJURIES AND POISONING 800-999 XVII;patients discharged per 100,000 inhabitants;males;931 INJURIES AND POISONING 800-999 XVII;patients discharged per 100,000 inhabitants;females;838 INJURIES AND POISONING 800-999 XVII;Average Stay by patient;both sexes;8 INJURIES AND POISONING 800-999 XVII;Average Stay by patient;males;7 INJURIES AND POISONING 800-999 XVII;Average Stay by patient;females;9 FRACTURES 800-829 XVII.1;patients discharged per 100,000 inhabitants;both sexes;426 FRACTURES 800-829 XVII.1;patients discharged per 100,000 inhabitants;males;392 FRACTURES 800-829 XVII.1;patients discharged per 100,000 inhabitants;females;459 FRACTURES 800-829 XVII.1;Average Stay by patient;both sexes;8 FRACTURES 800-829 XVII.1;Average Stay by patient;males;8 FRACTURES 800-829 XVII.1;Average Stay by patient;females;9 Fracture of the cranium 800-804;patients discharged per 100,000 inhabitants;both sexes;26 Fracture of the cranium 800-804;patients discharged per 100,000 inhabitants;males;38 Fracture of the cranium 800-804;patients discharged per 100,000 inhabitants;females;13 Fracture of the cranium 800-804;Average Stay by patient;both sexes;7 Fracture of the cranium 800-804;Average Stay by patient;males;7 Fracture of the cranium 800-804;Average Stay by patient;females;7 Fractures of the neck and trunk 805-809;patients discharged per 100,000 inhabitants;both sexes;52 Fractures of the neck and trunk 805-809;patients discharged per 100,000 inhabitants;males;53 Fractures of the neck and trunk 805-809;patients discharged per 100,000 inhabitants;females;51 Fractures of the neck and trunk 805-809;Average Stay by patient;both sexes;11 Fractures of the neck and trunk 805-809;Average Stay by patient;males;11 Fractures of the neck and trunk 805-809;Average Stay by patient;females;10 Fracture of radius & ulna 813 *;patients discharged per 100,000 inhabitants;both sexes;53 Fracture of radius & ulna 813 *;patients discharged per 100,000 inhabitants;males;53 Fracture of radius & ulna 813 *;patients discharged per 100,000 inhabitants;females;53 Fracture of radius & ulna 813 *;Average Stay by patient;both sexes;3 Fracture of radius & ulna 813 *;Average Stay by patient;males;3 Fracture of radius & ulna 813 *;Average Stay by patient;females;3 Other fractures involving an upper limb 810-812.814-819 *;patients discharged per 100,000 inhabitants;both sexes;64 Other fractures involving an upper limb 810-812.814-819 *;patients discharged per 100,000 inhabitants;males;70 Other fractures involving an upper limb 810-812.814-819 *;patients discharged per 100,000 inhabitants;females;59 Other fractures involving an upper limb 810-812.814-819 *;Average Stay by patient;both sexes;5 Other fractures involving an upper limb 810-812.814-819 *;Average Stay by patient;males;4 Other fractures involving an upper limb 810-812.814-819 *;Average Stay by patient;females;5 Fractures of the femur 820-821 *;patients discharged per 100,000 inhabitants;both sexes;144 Fractures of the femur 820-821 *;patients discharged per 100,000 inhabitants;males;81 Fractures of the femur 820-821 *;patients discharged per 100,000 inhabitants;females;205 Fractures of the femur 820-821 *;Average Stay by patient;both sexes;13 Fractures of the femur 820-821 *;Average Stay by patient;males;13 Fractures of the femur 820-821 *;Average Stay by patient;females;13 Fracture of tibia & fibula, fracture of ankle 823-824 *;patients discharged per 100,000 inhabitants;both sexes;69 Fracture of tibia & fibula, fracture of ankle 823-824 *;patients discharged per 100,000 inhabitants;males;75 Fracture of tibia & fibula, fracture of ankle 823-824 *;patients discharged per 100,000 inhabitants;females;64 Fracture of tibia & fibula, fracture of ankle 823-824 *;Average Stay by patient;both sexes;6 Fracture of tibia & fibula, fracture of ankle 823-824 *;Average Stay by patient;males;6 Fracture of tibia & fibula, fracture of ankle 823-824 *;Average Stay by patient;females;6 Other fractures involving a lower limb 822.825-829 *;patients discharged per 100,000 inhabitants;both sexes;18 Other fractures involving a lower limb 822.825-829 *;patients discharged per 100,000 inhabitants;males;23 Other fractures involving a lower limb 822.825-829 *;patients discharged per 100,000 inhabitants;females;14 Other fractures involving a lower limb 822.825-829 *;Average Stay by patient;both sexes;6 Other fractures involving a lower limb 822.825-829 *;Average Stay by patient;males;6 Other fractures involving a lower limb 822.825-829 *;Average Stay by patient;females;6 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;patients discharged per 100,000 inhabitants;both sexes;64 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;patients discharged per 100,000 inhabitants;males;87 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;patients discharged per 100,000 inhabitants;females;41 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;Average Stay by patient;both sexes;2 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;Average Stay by patient;males;2 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;Average Stay by patient;females;3 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;patients discharged per 100,000 inhabitants;both sexes;67 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;patients discharged per 100,000 inhabitants;males;83 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;patients discharged per 100,000 inhabitants;females;51 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;Average Stay by patient;both sexes;9 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;Average Stay by patient;males;9 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;Average Stay by patient;females;8 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;patients discharged per 100,000 inhabitants;both sexes;38 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;patients discharged per 100,000 inhabitants;males;57 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;patients discharged per 100,000 inhabitants;females;20 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;Average Stay by patient;both sexes;5 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;Average Stay by patient;males;5 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;Average Stay by patient;females;5 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;patients discharged per 100,000 inhabitants;both sexes;34 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;patients discharged per 100,000 inhabitants;males;38 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;patients discharged per 100,000 inhabitants;females;30 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;Average Stay by patient;both sexes;5 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;Average Stay by patient;males;5 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;Average Stay by patient;females;6 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;patients discharged per 100,000 inhabitants;both sexes;3 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;patients discharged per 100,000 inhabitants;males;4 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;patients discharged per 100,000 inhabitants;females;3 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;Average Stay by patient;both sexes;6 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;Average Stay by patient;males;6 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;Average Stay by patient;females;7 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;patients discharged per 100,000 inhabitants;both sexes;30 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;patients discharged per 100,000 inhabitants;males;34 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;patients discharged per 100,000 inhabitants;females;27 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;Average Stay by patient;both sexes;5 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;Average Stay by patient;males;4 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;Average Stay by patient;females;5 BURNS 940-949 XVII.6;patients discharged per 100,000 inhabitants;both sexes;9 BURNS 940-949 XVII.6;patients discharged per 100,000 inhabitants;males;12 BURNS 940-949 XVII.6;patients discharged per 100,000 inhabitants;females;6 BURNS 940-949 XVII.6;Average Stay by patient;both sexes;12 BURNS 940-949 XVII.6;Average Stay by patient;males;11 BURNS 940-949 XVII.6;Average Stay by patient;females;12 POISONING AND TOXIC EFFECTS 960-989 XVII.7;patients discharged per 100,000 inhabitants;both sexes;25 POISONING AND TOXIC EFFECTS 960-989 XVII.7;patients discharged per 100,000 inhabitants;males;24 POISONING AND TOXIC EFFECTS 960-989 XVII.7;patients discharged per 100,000 inhabitants;females;26 POISONING AND TOXIC EFFECTS 960-989 XVII.7;Average Stay by patient;both sexes;6 POISONING AND TOXIC EFFECTS 960-989 XVII.7;Average Stay by patient;males;6 POISONING AND TOXIC EFFECTS 960-989 XVII.7;Average Stay by patient;females;6 Poisoning by drugs, medicaments and biological substances 960-979;patients discharged per 100,000 inhabitants;both sexes;20 Poisoning by drugs, medicaments and biological substances 960-979;patients discharged per 100,000 inhabitants;males;18 Poisoning by drugs, medicaments and biological substances 960-979;patients discharged per 100,000 inhabitants;females;22 Poisoning by drugs, medicaments and biological substances 960-979;Average Stay by patient;both sexes;6 Poisoning by drugs, medicaments and biological substances 960-979;Average Stay by patient;males;6 Poisoning by drugs, medicaments and biological substances 960-979;Average Stay by patient;females;6 Toxic effects of substances chiefly nonmedicinal as to source 980-989;patients discharged per 100,000 inhabitants;both sexes;5 Toxic effects of substances chiefly nonmedicinal as to source 980-989;patients discharged per 100,000 inhabitants;males;6 Toxic effects of substances chiefly nonmedicinal as to source 980-989;patients discharged per 100,000 inhabitants;females;4 Toxic effects of substances chiefly nonmedicinal as to source 980-989;Average Stay by patient;both sexes;5 Toxic effects of substances chiefly nonmedicinal as to source 980-989;Average Stay by patient;males;5 Toxic effects of substances chiefly nonmedicinal as to source 980-989;Average Stay by patient;females;5 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;patients discharged per 100,000 inhabitants;both sexes;12 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;patients discharged per 100,000 inhabitants;males;12 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;patients discharged per 100,000 inhabitants;females;12 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;Average Stay by patient;both sexes;6 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;Average Stay by patient;males;6 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;Average Stay by patient;females;7 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;patients discharged per 100,000 inhabitants;both sexes;209 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;patients discharged per 100,000 inhabitants;males;226 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;patients discharged per 100,000 inhabitants;females;194 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;Average Stay by patient;both sexes;10 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;Average Stay by patient;males;10 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;Average Stay by patient;females;10 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;patients discharged per 100,000 inhabitants;both sexes;247 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;patients discharged per 100,000 inhabitants;males;246 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;patients discharged per 100,000 inhabitants;females;249 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;Average Stay by patient;both sexes;6 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;Average Stay by patient;males;6 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;Average Stay by patient;females;6 DISCHARGES WITHOUT DIAGNOSIS;patients discharged per 100,000 inhabitants;both sexes;58 DISCHARGES WITHOUT DIAGNOSIS;patients discharged per 100,000 inhabitants;males;58 DISCHARGES WITHOUT DIAGNOSIS;patients discharged per 100,000 inhabitants;females;59 DISCHARGES WITHOUT DIAGNOSIS;Average Stay by patient;both sexes;7 DISCHARGES WITHOUT DIAGNOSIS;Average Stay by patient;males;8 DISCHARGES WITHOUT DIAGNOSIS;Average Stay by patient;females;7